Clinical Study to Evaluate the Efficacy and Safety of GS1-144 Tablets in the Treatment of Moderate to Severe Vasomotor Symptoms in Chinese Postmenopausal Women.

In the placebo arm, participants will consume a placebo matching GenSci1-144 for 12 consecutive weeks.

In the GS1-144 arm, participants will receive multiple doses of GS1-144 tablets for 12 consecutive weeks